Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Tumor Metabolome Targeting and Drug Development, Paperback / softback Book

Tumor Metabolome Targeting and Drug Development Paperback / softback

Edited by Steven Kanner

Part of the Cancer Drug Discovery and Development series

Paperback / softback

Description

In this volume, the major metabolic alterations identified in cancer and tumor-associated cells are explored, including discussions of former and emerging approaches to drug development in targeting cancer cell metabolism.

The metabolic network in cells promotes the generation of both energy and biomass needed for them to grow, divide and differentiate.

However, the metabolism of malignant cells generally varies from that of normal cells.

These differences provide a platform for the discovery of new approaches to targeting potential vulnerabilities in cancer cells for therapeutic options Some of the significant changes that occur involve ATP production and consumption that modulates the ATP to ADP ratio, hypoxia and the effects of reactive oxygen species on glycolysis, regulation of mitochondrial respiration, induction and suppression of autophagy, and the Warburg effect and “reverse” Warburg effect--these topics and more are discussed in this volume.

Information

Save 5%

£129.99

£123.05

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Cancer Drug Discovery and Development series  |  View all